Pasithea Therapeutics Corp. Common Stock

KTTA is trading at $0.56, +7.33% over the last 24 hours. Track live moves on the price chart at the top of this page.

The KTTA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. KTTA is currently trading at $0.56, +7.33% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on KTTA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. KTTA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from KTTA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against KTTA's historical range and other companies in the sector.

Pasithea Therapeutics Corp. Common Stock's market cap is currently --. Market cap is calculated as stock price × total shares outstanding.